"10.1371_journal.pone.0145380","plos one","2015-12-30T00:00:00Z","Anne Marie W Efsen; Anna Schultze; Frank A Post; Alexander Panteleev; Hansjakob Furrer; Robert F Miller; Marcelo H Losso; Javier Toibaro; Aliaksandr Skrahin; Jose M Miro; Joan A Caylà; Enrico Girardi; Mathias Bruyand; Niels Obel; Daria N Podlekareva; Jens D Lundgren; Amanda Mocroft; Ole Kirk; TB:HIV study group in EuroCoord","Centre for Health and Infectious Disease Research (CHIP), Department of Infectious Diseases and Rheumatology, CHIP, Finsencentret, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark; Department of Infection and Population Health, University College London Medical School, London, United Kingdom; Department of Sexual Health, Caldecot Centre, King's College Hospital, London, United Kingdom; Department of HIV/TB, TB hospital 2, St. Petersburg, Russia; Department of Infectious Diseases, Bern University Hospital and University of Bern, Bern, Switzerland; Centre for Sexual Health and HIV Research, Mortimer Market Centre, University College London, London, United Kingdom; Department of immunocompromised, Hospital J.M. Ramos Mejia, Buenos Aires, Argentina; Clinical Department, Republican Research and Practical Centre for Pulmonology and TB, Minsk, Belarus; Infectious Diseases Service, Hospital Clinic–IDIBAPS. University of Barcelona, Barcelona, Spain; Agencia de Salud Pública de Barcelona, Barcelona, España; Programa Integrado de Investigación en Tuberculosis de SEPAR (PII-TB); Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain; Department of Infectious Diseases INMI \"L. Spallanzani\", Ospedale L Spallanzani, Rome, Italy; INSERM, ISPED, Centre Inserm U897- Epidemiologie-Biostatistique, Bordeaux, France; Department of Infectious Diseases and Rheumatology, Finsencentret, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark","Conceived and designed the experiments: AWE ASC AM DNP JDL OK. Performed the experiments: AWE ASC AM DNP JDL OK. Analyzed the data: AWE ASC AM DNP JDL OK FP AP HF RM MHL JT ASK JMM JAC EG MB NO. Contributed reagents/materials/analysis tools: AWE ASC AM DNP JDL OK FP AP HF RM MHL JT ASK JMM JAC EG MB NO. Wrote the paper: AWE ASC AM DNP JDL OK FP AP HF RM MHL JT ASK JMM JAC EG MB NO. Performed statistical analyses: ASC AM.","AMW reports a personal grant from University Hospital Copenhagen. AS reports grants and travel support from University College London. HF reports consultancy fees from ViiV, Gilead, Abbvie, MSD, Jannsen, BMS and grants from ViiV, Gilead, AbbVie, Roche, Boehringer, MSD, BMS, Janssen outside the submitted work. RM reports payment for lectures from ViiV, Merck, Gilead and Janssen outside the submitted work. JMM reports consultancy fees from Abbvie, Novartis, payment for lectures from Abbvie, Bristol-Myers Squibb, Gilead Sciences, Merck and Novartis y ViiV Healthcare and grants from Cubist, Gilead, ViiV Healthcare, Novartis, Merck, Fondo de Investigaciones Sanitarias - Instituto de Salud Carlos III, Fundación para la Investigación y Prevención del Sida en España, Ministerio de Sanidad, Servicios Sociales e Igualdad, National Institutes of Health and NEAT outside the submitted work. EG reports board membership for Janssen-Cilag, consultancy fees from Abbot-Diagnostics, payment for lectures from BMS, ViiV Healthcare, Jannsen and grants from Gilead Sciences outside the submitted work. JT reports grants from EuroCoord and University of Buenos Aires, CICAL during conduct of the study. MHL reports grants from EuroCoord, employment from University of Buenos Aires, Hospital JM Ramos Mejia, CICAL and grants from NIH, University of Minnesota, University of New South Wales, travel fees from Gador outside the submitted work. AM reports speaker fees, travel fees and honorarium from BI, Gilead, Pfizer, Merck and BMS outside the submitted work. OK reports board membership from Gilead, Merck, ViiV, consultancy fees from Gilead, payment for lectures from Abbott, Gilead, Tibotec, travel fees from Abbott, BMS, Gilead, Merck, ViiV and grants from Bristol-Myers Squibb, Janssen, Merck, Pfizer, GlaxoSmithKline outside the submitted work. For the remaining authors, none were declared. Although several authors have received grants, honoraria or travel support from a number of pharmaceutical companies, none have declared a conflict of interest in relation to the work presented in this manuscript. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.","2015","12","Anne Marie W Efsen","AMWE",19,TRUE,6,6,18,18,TRUE,TRUE,TRUE,3,"2;9;19",TRUE
